News | May 11, 2024
Dr. Lal PathLabs posts Q4 FY24 consolidated PAT at Rs. 84.5 Cr
The company has posted net profit of Rs.357.7 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.357.7 crores for the Financial Year ended March 31, 2024
Ami Organics has reported total income of Rs. 226.30 crores during the period ended March 31, 2024
The company is committed to address this observation comprehensively within stipulated time
The company has posted net profit of Rs.118.82 crores for the Financial Year ended March 31, 2024
ORACEA is a trademark of Galderma Holdings, S.A.
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
The company has posted net profit of Rs.30.35 crores for the Financial Year ended March 31, 2024
Glenmark’s Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the U.S. by Glenmark Therapeutics, USA
The QC Lab is equipped with advanced instruments to ensure rigorous quality control across all manufacturing processes
Subscribe To Our Newsletter & Stay Updated
